Xiaolin Pharmaceutical (China) Co., Ltd. chooses contract lock
Recently, Xiaolin Pharmaceutical (China) Co., Ltd. chose contract lock and established a digital trust foundation by deploying an electronic signature and seal management platform, making the digital process trustworthy; Effective· Security· Verifiable· Check it out! Kobayashi Pharmaceutical (China) Co., Ltd. was established in April 2018, with its registered address located on Chundong Road, Minhang District, Shanghai. Kobayashi Pharmaceutical (China) Co., Ltd. is a wholly-owned subsidiary of Kobayashi Pharmaceutical Co., Ltd., a Japanese listed company. An enterprise primarily engaged in product development, primarily engaged in the research, development, production, and sales of drugs, medical devices, daily necessities, food, and other products. The product is not only sold domestically in Japan, but also to various parts of the world such as the United States, the United Kingdom, and Southeast Asia. Since its establishment, Xiaolin Pharmaceutical (China) Co., Ltd. has not only provided high-quality and high value-added products to Chinese consumers, but also served as an important investment, research and development, and sales base within the Xiaolin Group, becoming an indispensable component of the group. Along with its rapid development, the company has put forward new digital requirements for business management and daily office operations. This time, Xiaolin Pharmaceutical (China) Co., Ltd. has chosen Contract Lock, which provides a trusted foundation for the organization's digital construction through the Contract Lock Digital Trusted Platform. strong data
-Tag apply id="strong-53776b0d">Contract locks support the printing and signing needs of the core business of the pharmaceutical industry:
Contract locks help the pharmaceutical industry build an electronic printing control platform, fully realizing the“ Electronic seal+physical seal” Unified control, integrated with ERP, OA, CRM, and SRM supplier management software, enables pharmaceutical enterprises to easily call contract lock electronic signatures in the process flow of various businesses, promoting the development of; Drug registration, production, testing, and distribution; Waiting for business documents to be implemented; Online approval, stamping, signing, verification, and retention; Assist pharmaceutical companies in achieving digital transformation. Click to enter and try it for free now!